We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00718055
Recruitment Status : Withdrawn
First Posted : July 18, 2008
Last Update Posted : February 10, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan

Condition or disease Phase
Neoplasm Metastasis Liver Colorectal Neoplasms Magnetic Resonance Imaging Contrast Media Phase 4

Study Design

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: MR Skanning Med Leverspecifikt Oralt Kontraststof Sammenlignet Med CT Skanning Hos Colorectalcancer Patienter Med Levermetastaser
Study Start Date : November 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
consekutive group of liver metastatic patients
Criteria

Inclusion Criteria:

  • biopsy proved liver metastasis

Exclusion Criteria:

  • pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00718055


Locations
Denmark
Copenhagen Uni. Hospital at Herlev dept. of Radiology
Herlev, Denmark, 2730
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Investigators
Principal Investigator: Vibeke Løgager, M.D. Copenhagen University Hospital at Herlev
More Information

Responsible Party: Vibeke Løgager, Herlev Hospital
ClinicalTrials.gov Identifier: NCT00718055     History of Changes
Other Study ID Numbers: KA-20060096
First Posted: July 18, 2008    Key Record Dates
Last Update Posted: February 10, 2009
Last Verified: February 2009

Keywords provided by Copenhagen University Hospital at Herlev:
MRI
liverspecific
contrast
colorectal
metastases

Additional relevant MeSH terms:
Neoplasms
Neoplasm Metastasis
Colorectal Neoplasms
Neoplastic Processes
Pathologic Processes
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases